Patent number: 9763900
Abstract: This invention relates to chemistry and biochemistry applied to the field of medicine and is referred to a new method of prevention and therapeutic treatment of conformational diseases (CD), in particular to amyloid origin diseases by administrating an effective amount of one or more compounds, salts, prodrugs or solvates, which are considered herein as chemical chaperonins, of Formula I, Where: R1: -alkylenyl-C(O)NH-alkylenyl-R3, -alkylenyl-C(O)O—R4; R3: —COOH, —OH, —SH, —NH2, —NH-alkyl-, —NH-dithiocarbamate-alkyl, —N-alkyl-dithiocarbamate alkaline earth metal salts. R4: succinimidyl group. R2: —H, -alkyl; wherein the term “alkyl” is characterized by a linear or branched aliphatic chain, hydrogen and saturated carbon atoms, comprising a methyl, ethyl, n-propyl, iso-propyl, n-butyl or iso-butyl groups. Wherein, the term “alkylenyl” refers to a divalent analog of a linear or branched alkyl group, preferably ethylenyl (—CH2CH2—) or butylenyl (—CH2CH2CH2CH2—) radicals.
Type:
Grant
Filed:
December 30, 2013
Date of Patent:
September 19, 2017
Assignee:
CENTRO DE NEUROCIENCIAS DE CUBA
Inventors:
Marquiza Sablón Carrazana, Chryslaine Rodriguez-Tanty, Myriam Marlene Altamirano Bustamante, Fernand Vedrenne Gutiérrez, Suchitil Rivera Marrero, Isaac Fernández Gómez, Rosa María López Barroso, Lina Andrea Rivillas Acevedo, Reyna Lara Martinez, Rafaela Perez Perera, Alberto Bencomo Martínez, María Guadalupe Domínguez Macouzet, Luis Felipe Jiménez García, Massiel Díaz Miranda, Julio Morán Andrade, Pedro Valdés Sosa, Alejandro Perera Pintado, Anaís Prats Capote, Sergio Agustín Islas Andrade
Publication number: 20160106691
Abstract: This invention relates to chemistry and biochemistry applied to the field of medicine and is referred to a new method of prevention and therapeutic treatment of conformational diseases (CD), in particular to amyloid origin diseases by administrating an effective amount of one or more compounds, salts, prodrugs or solvates, which are considered herein as chemical chaperonins, of Formula I, Where: R1: -alkylenyl-C(O)NH-alkylenyl-R3, -alkylenyl-C(O)O—R4; R3: —COOH, —OH, —SH, —NH2, —NH-alkyl-, —NH-dithiocarbamate-alkyl, —N-alkyl-dithiocarbamate alkaline earth metal salts. R4: succinimidyl group. R2: —H, -alkyl; wherein the term “alkyl” is characterized by a linear or branched aliphatic chain, hydrogen and saturated carbon atoms, comprising a methyl, ethyl, n-propyl, iso-propyl, n-butyl or iso-butyl groups. Wherein, the term “alkylenyl” refers to a divalent analog of a linear or branched alkyl group, preferably ethylenyl (—CH2CH2—) or butylenyl (—CH2CH2CH2CH2—) radicals.
Type:
Application
Filed:
December 30, 2013
Publication date:
April 21, 2016
Inventors:
MARQUIZA SABLON CARRAZANA, Chrislayne RODRIGUEZ-TANTY, Myriam Marlene ALTAMIRANO BUSTAMANTE, Fernand Vedrenne GUTIERREZ, Suchitil RIVERA MARRERO, Isaac Gomez FERNANDEZ, Rosa Maria LOPEZ BARROSO, Lina Andrea RIVILLAS ACEVEDOº, Reyna LARA MARTINEZ, Rafaela PEREZ PERERA, Alberto Guadalupe BENCOMO MARTINEZ, Maria Guadalupe DOMINGUEZ MACOUZET, Luis Felipe JIMENEZ GARCIA, Massiel DIAZ MIRANDA, Andreade Julio MORAN, Pedro VALDES SOSA, Alejandro PERERA PINADO, Anais PRATS CAPOTE, Sergio Agustin ISLAS ANDRADE
